We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+9.06%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.65B
AUM Growth
+$213M
Cap. Flow
+$127M
Cap. Flow %
7.68%
Top 10 Hldgs %
13.99%
Holding
1,616
New
434
Increased
384
Reduced
359
Closed
375

Sector Composition

Rank Sector Weight
1 Technology 14.94%
2 Consumer Discretionary 9.59%
3 Healthcare 9.5%
4 Industrials 8.56%
5 Communication Services 6.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
701
CALL
Apple
AAPL
$4.5T
$419K 0.03%
1,800
-1,200
-40% -$268K
COST icon
702
Costco
COST
$423B
$417K 0.03%
+470
New +$408K
DNOW icon
703
DNOW Inc
DNOW
$3.01B
$415K 0.03%
32,127
+15,883
+98% +$210K
GH icon
704
Guardant Health
GH
$22.4B
$415K 0.03%
18,100
-1,613
-8% -$45.7K
SPHD icon
705
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.39B
$413K 0.03%
8,172
-3,272
-29% -$157K
F icon
706
Ford
F
$55.8B
$411K 0.02%
38,909
+9,205
+31% +$105K
AMD icon
707
PUT
Advanced Micro Devices
AMD
$767B
$410K 0.02%
2,500
SXC icon
708
SunCoke Energy
SXC
$799M
$410K 0.02%
47,218
+16,221
+52% +$150K
NU icon
709
Nu Holdings
NU
$67B
$410K 0.02%
30,000
-13,694
-31% -$184K
IWO icon
710
iShares Russell 2000 Growth ETF
IWO
$14.9B
$409K 0.02%
+1,440
New +$394K
XBI icon
711
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$408K 0.02%
+4,130
New +$406K
DV icon
712
DoubleVerify
DV
$2.03B
$408K 0.02%
+24,221
New +$462K
DIN icon
713
Dine Brands
DIN
$453M
$407K 0.02%
+13,030
New +$420K
FAF icon
714
First American
FAF
$7.37B
$406K 0.02%
+6,150
New +$375K
OVV icon
715
Ovintiv
OVV
$17.6B
$406K 0.02%
+10,588
New +$458K
CAL icon
716
Caleres
CAL
$486M
$404K 0.02%
12,230
+4,566
+60% +$166K
MEDP icon
717
Medpace
MEDP
$16.8B
$403K 0.02%
1,207
+236
+24% +$89.7K
BKV
718
BKV Corp
BKV
$2.81B
$402K 0.02%
+22,000
New +$398K
KB icon
719
KB Financial Group
KB
$42.4B
$401K 0.02%
6,500
-5,000
-43% -$311K
ESPR
720
DELISTED
Esperion Therapeutics
ESPR
$401K 0.02%
242,847
-28,042
-10% -$56.6K
EXPD icon
721
Expeditors International
EXPD
$23.3B
$400K 0.02%
3,047
+77
+3% +$9.43K
PKG icon
722
Packaging Corp of America
PKG
$22.7B
$398K 0.02%
1,850
-773
-29% -$154K
TPG icon
723
TPG
TPG
$7.93B
$398K 0.02%
6,917
-2,683
-28% -$132K
ORI icon
724
Old Republic International
ORI
$10.3B
$397K 0.02%
+11,220
New +$380K
MSCI icon
725
MSCI
MSCI
$40.9B
$397K 0.02%
681
-446
-40% -$242K

Similar funds

Prelude Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Prelude Capital Management held 1,616 positions worth $1.65B, up 15% from $1.44B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Prelude Capital Management deployed $127M of net new capital in Q3 2024, opening 434 new positions and adding to 384 existing holdings. Its largest new stake was Kellanova: 90,625 shares worth $7.31M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Western Digital, an estimated $8.43M trimmed.

  • Prelude Capital Management's largest Q3 2024 buy was Kellanova: 90,625 shares worth $7.31M.
  • Prelude Capital Management added most to Elastic in Q3 2024, an estimated $6.65M increase.
  • Prelude Capital Management's biggest Q3 2024 reduction was Western Digital, cutting an estimated $8.43M.
  • Prelude Capital Management fully exited Cerevel Therapeutics Holdings, Inc. Common Stock in Q3 2024, selling an estimated $11.1M.
  • Prelude Capital Management's ten largest holdings make up 14% of its $1.65B portfolio in Q3 2024.
  • Prelude Capital Management opened 434 new positions and closed 375 in Q3 2024.
  • Prelude Capital Management's portfolio value rose 15% quarter-over-quarter to $1.65B.

Based on Prelude Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.